Doxycycline Plus Streptomycin Versus Ciprofloxacin Plus Rifampicin in Spinal Brucellosis

Completed

• Conditions: Brucellosis is an infectious disease affecting multiple systems including vertebrae; Infections and Infestations; Spinal brucellosis

• Registration Number: ISRCTN31053647
• Lead Sponsor: Erciyes University Medical School (Turkey)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-03-29
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 31

Inclusion Criteria

The patients diagnosed with spinal brucellosis between January 2002 to December 2004 were enrolled into two study groups consecutively

Exclusion Criteria

1. Age less than 16 years
2. Pregnancy
3. Neurobrucellosis
4. Previous history of brucellosis and antimicrobial therapy and discontinuation of the therapy for any reason (allergy to any of the drugs, death, adverse reactions)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Clinical efficacy of ciprofloxacin plus rifampicin in spinal brucellosis<br>2. The prevalence of relapses

Secondary Outcome Measures

Name	Time	Method
The cost of the two regimens